Promethazine Dosing for Nausea in Adults
For nausea and vomiting in adults, administer promethazine 12.5-25 mg orally or intravenously every 4-6 hours as needed, with the FDA-approved standard dose being 25 mg. 1
Standard Dosing Recommendations
The FDA label establishes the following dosing parameters for nausea and vomiting 1:
- Initial dose: 25 mg (oral, IV, or rectal)
- Repeat dosing: 12.5-25 mg every 4-6 hours as needed
- Prophylactic dosing: 25 mg repeated at 4-6 hour intervals for prevention during surgery and postoperative period
Evidence-Based Lower Dose Options
Consider starting with 6.25-12.5 mg IV for comparable efficacy with reduced sedation, particularly when sedation is undesirable or when used with opioids 2, 3:
- 6.25 mg IV provides 74% relief at 1 hour, equivalent to ondansetron 4 mg, with significantly fewer adverse effects 2
- 12.5 mg IV achieves 68% relief at 1 hour with minimal difference in efficacy compared to 6.25 mg 2
- Lower doses (6.25 mg) result in less sedation at discharge compared to 12.5 mg, while maintaining equivalent antiemetic efficacy 3
Clinical Context and Route Selection
Oral/Rectal Administration
- Standard dose: 25 mg every 4-6 hours 1
- Reduced dose: 12.5 mg may be appropriate when sedation is problematic 1
- Oral bioavailability is approximately 25%, though FDA dosing does not differentiate by route 2
Intravenous Administration
- Infuse slowly to minimize hypotension risk 4
- Clinical effects evident within 5 minutes, duration 4-6 hours 4
- 12.5-25 mg IV is the recommended range for procedural sedation as adjunct to narcotics 4
Special Clinical Situations
Opioid-Induced Nausea
The NCCN guidelines specifically recommend promethazine 12.5-25 mg PO every 6 hours for patients with prior history of opioid-induced nausea 5:
- Use prophylactically in patients with known opioid-induced nausea 5
- Consider as breakthrough treatment for chemotherapy-induced nausea at 12.5-25 mg PO or IV every 4 hours 4
Cyclic Vomiting Syndrome
- 12.5-25 mg orally or rectally every 4-6 hours as abortive therapy during acute episodes 4
Elderly Patients
Start with 6.25 mg IV in patients ≥65 years 6:
- 6.25 mg is as effective as higher doses with significantly fewer adverse drug reactions (P = 0.048) 6
- No difference in time to relief between 6.25 mg and 12.5 mg groups 6
Critical Safety Considerations
Sedation Profile
- CNS depression and sedation occur frequently, which may be advantageous when sedation is desired but problematic otherwise 4
- Promethazine is more sedating than prochlorperazine, metoclopramide, or ondansetron 7
- Use cautiously when combined with opioids or other CNS depressants 4
Other Adverse Effects
- Hypotension with rapid IV administration 4
- Respiratory depression potential 4
- Extrapyramidal symptoms can develop, similar to other dopamine antagonists 4
- Dizziness, blurred vision, dry mouth 4
Contraindications
Practical Algorithm for Dose Selection
- Start with 12.5 mg IV/PO for most adult patients with nausea 1
- Use 6.25 mg IV if patient is elderly (≥65 years), receiving concurrent opioids, or when sedation is undesirable 2, 6
- Escalate to 25 mg if inadequate response after 4-6 hours 1
- Maximum single dose: 25 mg 1
- Repeat every 4-6 hours as needed 1
When Promethazine May Be Preferred
Promethazine is particularly useful when 4, 7:
- Sedation is beneficial (nighttime dosing, anxious patients)
- Other antiemetics have failed
- Cost is a consideration
- Opioid-induced pruritus is also present (dual benefit as antihistamine)